NCT02819739View on ClinicalTrials.gov

Impact of Hyperoxia During Cardiopulmonary

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

November 11, 2014

Primary Completion Date

October 10, 2018

Study Completion Date

March 30, 2019

Conditions
Cardiac Complications
Interventions
DRUG

medical oxygen

Trial Locations (2)

21079

CHU Dijon-Bourgogne, Dijon

80054

CHU Amiens-Picardie, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT02819739 - Impact of Hyperoxia During Cardiopulmonary | Biotech Hunter | Biotech Hunter